Pharmaceuticals

This sector can once again be considered to be a sector with a particularly high R&D content. This is reflected in the good Sustainable Value performance of the four companies of this sector. Among the companies of this sector we have analysed Novonordisk, the best company of this sector, is about 3 times more efficient than Richter, the worst performing company in this sector.


Pharmaceuticals  RCR 2003  Rank RCR 2003 
Novonordisk   4.4 : 1 
Schering  3.8 : 1 
AstraZeneca   2.1 : 1  18 
Richter   1.5 : 1  24 

Water use and SOX-emissions are the most important Sustainable Value drivers in this sector. CO2-emissions are the most critical resource both in 2003 and the 2010 future performance scenario. However, performances with regard to specific environmental impacts vary widely across this sector. This can be shown by comparing the performance of the sector leader and the sector laggard by way of example. In 2003, Novonordisk used VOC-emissions 45 times, water 20 times and waste 12 times more efficiently than Richter.


Return to Cost Ratios  2003    2003 > 2010 
CO2-emissions   4.6 : 1    3.3 : 1 
NOx-emissions  9.3 : 1    4.8 : 1 
SOx-emissions  14.4 : 1    8.1 : 1 
Waste generated   12.4 : 1    7.9 : 1 
Water used   20.3 : 1    16 : 1 
VOC-emissions   11.4 : 1    5.4 : 1 

Click here to go back to the sector overview.


(C) 2006 - All rights reserved

Print this page